Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark DiPaolo Insider Profile
4 Followers
Mark DiPaolo, Director at Novelion Therapeutics, holds ― shares in Novelion Therapeutics (Ticker: NVLNF), holds 118.63K shares in Innoviva (Ticker: INVA), holds ― shares in Amarin (Ticker: AMRN). Most recently, Mark DiPaolo ― shares of Novelion Therapeutics on ― for an estimated value of ―.
Mark DiPaolo Novelion Therapeutics (NVLNF)Director
Novelion Therapeutics (NVLNF)
Director
Not Ranked
Mark DiPaolo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Mark DiPaolo
Mark DiPaolo's Trading History
Novelion Therapeutics
―
―
―
―
Innoviva
Jun 20, 2024
Director
Uninformative Buy
―
$2.20M
Amarin
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Mark DiPaolo's performance on stock
You May Also Like
Mark DiPaolo insider profile FAQ
What is the percentage of profitable transactions made by Mark DiPaolo?
The percentage of profitable transactions made by Mark DiPaolo is ―.
What is the average return per transaction made by Mark DiPaolo?
The average return per transaction made by Mark DiPaolo is ―.
What stocks does Mark DiPaolo hold?
Mark DiPaolo holds: NVLNF, INVA, AMRN stocks.
What was Mark DiPaolo’s latest transaction?
Mark DiPaolo latest transaction was an Uninformative Buy of ―.
What was Mark DiPaolo's most profitable transaction?
Mark DiPaolo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark DiPaolo's role in Novelion Therapeutics?
Mark DiPaolo's role in Novelion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.